Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)

Barbara Schwartzberg, John Lewin, Osama Abdelatif, Jacqueline Bernard, Hanadi Bu-Ali, Simon Cawthorn, Margaret Chen-Seetoo, Sheldon Feldman, Sasirekha Govindarajulu, Lyn Jones, Arne Juette, Sanjay Kavia, Robert Maganini, Simon Pain, Mike Shere, Craig Shriver, Simon Smith, Alexandra Valencia, Eric Whitacre, Roger Whitney

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

The article “Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations”, written by Barbara Schwartzberg et al., was originally published electronically on the publisher’s internet portal (currently SpringerLink) on July 9, 2018, without open access.

Original languageEnglish (US)
Pages (from-to)998
Number of pages1
JournalAnnals of Surgical Oncology
Volume25
DOIs
StatePublished - Dec 17 2018

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)'. Together they form a unique fingerprint.

Cite this